The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. by Merkel, P, Aydin, S, Boers, M, Direskeneli, H, Herlyn, K, Seo, P, Suppiah, R, Tomasson, G, Luqmani, R

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. by Direskeneli, H, Aydin, S, Kermani, T, Matteson, E, Boers, M, Herlyn, K, Luqmani, R, Neogi, T, Seo, P, Suppiah, R, Tomasson, G, Merkel, P

Current status of outcome measure development in vasculitis. by Merkel, P, Aydin, S, Boers, M, Cornell, C, Direskeneli, H, Gebhart, D, Hatemi, G, Luqmani, R, Matteson, E, Milman, N, Robson, J, Seo, P, Tomasson, G

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis by Robson, J, Tomasson, G, Milman, N, Ashdown, S, Boonen, A, Casey, G, Cronholm, P, Cuthbertson, D, Dawson, J, Direskeneli, H, Easley, E, Kermani, T, Farrar, J, Gebhart, D, Lanier, G, Luqmani, R, Mahr, A, McAlear, C, Peck, J, Shea, B, Shea, J, Sreih, A, Tugwell, P, Merkel, P

The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participati... by Grøn, K, Ornbjerg, L, Hetland, M, Aslam, F, Khan, N, Jacobs, J, Henrohn, D, Rasker, J, Kauppi, M, Lang, H, Mota, L, Aggarwal, A, Yamanaka, H, Badsha, H, Gossec, L, Cutolo, M, Ferraccioli, G, Gremese, E, Bong Lee, E, Inanc, N, Direskeneli, H, Taylor, P, Huisman, M, Alten, R, Pohl, C

A disease-associated gene desert directs macrophage inflammation through ETS2 by Stankey, CT, Bourges, C, Haag, LM, Turner-Stokes, T, Piedade, AP, Palmer-Jones, C, Papa, I, Silva dos Santos, M, Zhang, Q, Cameron, AJ, Legrini, A, Zhang, T, Wood, CS, New, FN, Randzavola, LO, Speidel, L, Brown, AC, Hall, A, Saffioti, F, Parkes, EC, Edwards, W, Direskeneli, H, Grayson, PC, Jiang, L, Knight, JC